Abstract: A liquid ejecting head includes: a plurality of head chips having a nozzle surface; a thermally conductive holder holding the plurality of head chips; a thermally conductive flow path structure provided with a flow path of a liquid supplied to the plurality of head chips; and a planar heater disposed between the holder and the flow path structure and along a direction parallel to the nozzle surface, in which the heater overlaps the plurality of head chips in a plan view.

Abstract: The weight of a body-to-be-conveyed constituting a conveying device is reduced, and the friction force between the sliding surface of the body-to-be-conveyed and the conveyance path is reduced. A body-to-be-conveyed that is a component of a conveying device that uses electromagnetic force as thrust and can move in a horizontal direction includes a mover in which a bottom surface is arranged so that a predetermined gap is formed in a vertical direction with respect to the sliding surface thereof, in which the mover includes a permanent magnet and a cover, a gap facing surface of the permanent magnet facing the gap includes one magnetic pole, the cover is installed on a side of the permanent magnet opposite from the gap facing surface in the vertical direction, the horizontal outermost diameter of the cover is larger than the horizontal outermost diameter of the permanent magnet, and the cover is formed of a flat plate.

Abstract: A liquid ejecting head includes: head chips including a first-head-chip and a second-head-chip; a holder holding the head chips; and a heater along a direction parallel to a nozzle surface. The first-head-chip and the second-head-chip are disposed to be offset from each other in both a first-direction and a second-direction parallel to the nozzle surface and intersecting with each other. When a first-side is one of the four sides of a virtual rectangle circumscribing the aggregate of the head chips and a second-side and a third-side are coupled to both ends of the first-side, the first-head-chip is in contact with the first-side and the third-side and the second-head chip is in contact with the second-side. The heater overlaps the head chips. A first-region surrounded by the first-side, the second-side, the first-head-chip, and the second-head-chip includes a first-outside-part positioned outside the outer edge of the heater.

Abstract: A liquid ejecting head supported by a support body includes: a first head chip; a holder having a holding portion holding the first head chip and a flange portion; and a heater heating the holding portion, in which the holding portion has a heat receiving portion receiving heat from the heater, and a shortest path of heat transferred through the holder from the heat receiving portion to the flange portion is bent or curved at two or more points.

Abstract: The present invention provides a transport device and a specimen analysis system including the transport device that reduce the pulsation of thrust for moving an object to be transported, reduce vibration of the object to be transported during transport, and realize stable transport. The transport device of the present invention includes a first electromagnet unit including a first tooth made of a magnetic body, a first core connected to the first tooth and made of a magnetic body, and a first winding formed around the first core; a second electromagnet unit including a second tooth installed adjacent to the first electromagnet unit and made of a magnetic body, a second core connected to the second tooth and made of a magnetic body, a second winding formed around the second core; and a magnetic coupling unit made of a magnetic body between the first tooth of the first electromagnet unit and the second tooth of the second electromagnet unit.

Abstract: The present invention provides a compound having excellent histone acetyl transferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.

Abstract: It is intended to provide a novel compound or a salt thereof, or crystals of the compound or the salt, which inhibit Axl and are useful in the treatment of a disease caused by hyperfunction of Axl, the treatment of a disease associated with hyperfunction of Axl, and/or the treatment of a disease involving hyperfunction of Axl. [Solution] The present invention provides a pyridone derivative having a tetrahydropyranylmethyl group represented by the following formula (I) having various substituents, or a salt thereof, or crystals of the compound or the salt (wherein R1, R2, R3, R4, R5, W, X, Y, and Z are each as defined in the specification).

Abstract: The present disclosure provides novel compounds or salts thereof, or crystals of the compounds or the salts, which inhibit Axl and are useful in the treatment of a disease caused by hyperfunction of Axl, the treatment of a disease associated with hyperfunction of Axl, and/or the treatment of a disease involving hyperfunction of Axl.

Abstract: An endoscope includes an insertion portion that has a tip portion to be inserted into an examination target from a tip side of the tip portion. The endoscope includes a lens unit that is disposed at the tip portion. The endoscope includes an image sensor that is disposed on an opposite side to the tip side of tip portion with respect to the lens unit. The endoscope includes a linear conductor that has a tip disposed at the tip side with respect to the image sensor and has a proximal end which is extended from the tip through inside the insertion portion.

Abstract: The present invention provides a compound having excellent histone acetyl transferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.

Abstract: An adhesive layer-equipped transparent plate includes a transparent plate having a first surface and a second surface; a first adhesive layer provided on the first surface; and a second adhesive layer provided on the second surface; wherein the transparent plate includes at least one of an exposed portion in a periphery of the first surface, where the first surface is exposed from the first adhesive layer, and an exposed portions in a periphery of the second surface, where the second surface is exposed from the second adhesive layer.

Abstract: A display device comprising a transparent substrate and a liquid crystal display device having a liquid crystal panel and a back light, disposed on the transparent substrate, which comprises: a transparent resin to bond the liquid crystal panel to the transparent substrate, a strip double-sided adhesive provided so as to surround the bonded liquid crystal panel and bonded on the transparent substrate, a flexible member bonded to an opposite side of the double-sided adhesive from the transparent substrate-bonded surface, and an attaching member to attach the back light, formed on an opposite side of the flexible member from the bonded surface.

Abstract: A display apparatus includes a transparent plate; a liquid crystal panel affixed to a main surface of the transparent plate; a backlight configured to illuminate the liquid crystal panel from a side opposite to the transparent plate; and a fixing support configured to fix the backlight to the transparent plate. The fixing support includes a first opposing part that opposes the main surface of the transparent plate, and a second opposing part that opposes an end surface of the backlight. The first opposing part is affixed to the main surface of the transparent plate, and the second opposing part is fastened with the end surface of the backlight by a male screw that penetrates through an elongated hole of the second opposing part, and a female screw that is mated with the male screw.

Abstract: The present disclosure provides novel compounds or salts thereof, or crystals of the compounds or the salts, which inhibit Axl and are useful in the treatment of a disease caused by hyperfunction of Axl, the treatment of a disease associated with hyperfunction of Axl, and/or the treatment of a disease involving hyperfunction of Axl.

Abstract: The position of a metal marker 5 relative to an optical fiber 6 is fixed, and the metal marker 5 can be moved up close to a target site such as a thrombus. It is preferable that the position, in an optical fiber longitudinal direction, of a front-end face of the optical fiber 6 is coincident with the position, in an optical fiber longitudinal direction, of a front-end face of the metal marker 5. More specifically, since the distance between the target site and the front end of the optical fiber 6 is known by radiography, it becomes unnecessary to use a large quantity of contrast agent and irradiate a laser beam depending on skill and intuition, and therefore an effective laser beam irradiation becomes possible.

Abstract: The present disclosure provides novel compounds or salts thereof, or crystals of the compounds or the salts, which inhibit Axl and are useful in the treatment of a disease caused by hyperfunction of Axl, the treatment of a disease associated with hyperfunction of Axl, and/or the treatment of a disease involving hyperfunction of Axl.

Abstract: An adhesive layer-equipped transparent plate includes a transparent plate having a first surface and a second surface; a first adhesive layer provided on the first surface; and a second adhesive layer provided on the second surface; wherein the transparent plate includes at least one of an exposed portion in a periphery of the first surface, where the first surface is exposed from the first adhesive layer, and an exposed portions in a periphery of the second surface, where the second surface is exposed from the second adhesive layer.

Abstract: An endoscope includes an insertion portion that has a tip portion to be inserted into an examination target from a tip side of the tip portion. The endoscope includes a lens unit that is disposed at the tip portion. The endoscope includes an image sensor that is disposed on an opposite side to the tip side of tip portion with respect to the lens unit. The endoscope includes a linear conductor that has a tip disposed at the tip side with respect to the image sensor and has a proximal end which is extended from the tip through inside the insertion portion.

Abstract: A display apparatus includes a transparent plate; a liquid crystal panel affixed to a main surface of the transparent plate; a backlight configured to illuminate the liquid crystal panel from a side opposite to the transparent plate; and a fixing support configured to fix the backlight to the transparent plate. The fixing support includes a first opposing part that opposes the main surface of the transparent plate, and a second opposing part that opposes an end surface of the backlight. The first opposing part is affixed to the main surface of the transparent plate, and the second opposing part is fastened with the end surface of the backlight by a male screw that penetrates through an elongated hole of the second opposing part, and a female screw that is mated with the male screw.

Abstract: A crystal of a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof has an excellent LCAT-activating effect and is useful as an active ingredient in a therapeutic or prophylactic agent for arteriosclerosis, arteriosclerotic heart disease, coronary heart disease (including heart failure, myocardial infarction, angina pectoris, cardiac ischemia, cardiovascular disturbance, and restenosis caused by angiogenesis), cerebrovascular disease (including stroke and cerebral infarction), peripheral vascular disease (including diabetic vascular complications), dyslipidemia, hypo-HDL-cholesterolemia, or renal disease, particularly, an anti-arteriosclerotic agent, wherein R1 is a hydrogen atom or a hydroxy group, and R is a 2-(trifluoromethyl)pyrimidin-5-yl group or a 5-(trifluoromethyl)pyrazin-2-yl group.